Strategy
Part of Patient Acquisition: The Version That Survives Contact With Reality
A Framework for Evaluating Patient Acquisition Tools
A framework for patient acquisition tools: run a consistent pilot, score usability, evidence and data handling, check U.S. compliance, and set retest triggers.
What to take away
- CDC PLACES estimates describe census tracts, counties and places, never the patients on your list.
- A Social Vulnerability Index rank is a planning input for access and language work.
- Every tool needs a synthetic-record pilot, a named owner, and an export path you have already tested.
- Score candidates on the same service, roles, output and failure case so the comparison holds.
- Keep the rejection log; the constraint that killed a tool may lift next quarter.
Patient acquisition tools sit across research, forms, scheduling, calls, reminders and reporting. Pick one only after you can name the decision it changes and the person who owns that decision. Common categories include scheduling and intake (Klara, Phreesia), call tracking and attribution (CallRail), CRM and marketing automation (Salesforce Health Cloud, HubSpot), and reputation management (Birdeye, Podium). These names illustrate categories; none is tested or scored here.
Use public health data inside its limits
The CDC PLACES Data Portal publishes current and prior releases of health outcomes, prevention, risk behaviors, disability and health-related social needs at several geographic levels. Each row describes a place and an estimate, not a patient.
Preserve five things whenever you cite it: release, measure, geography, method and limitation. A modeled tract estimate can shape where you open Saturday hours. It cannot tell you that a named person needs care, and no patient list belongs in the same file.
Treat vulnerability measures as planning inputs
CDC and ATSDR publish Social Vulnerability Index data and documentation, with a standing caution that databases change and that rankings are not directly comparable across years. Read the release notes and data dictionary before you use any field.
Use a place-based measure to ask better access questions: language, transport, hours, partnership. A rank is not a label for an individual, and it does not replace asking the community directly. A patient acquisition checklist keeps those inputs tied to a documented release.
Score the whole tool, not the demo
Score the whole tool
Test
- Purpose
- One documented decision
- Access
- Representative user finishes the task
- Data
- Field-level trace to destination
- Evidence
- Export and reconciliation
- Failure
- Outage, retry, correction path
- Exit
- Export, deletion, access removal
Reject when
- Purpose
- Use is vague or expands silently
- Access
- Critical users cannot complete it
- Data
- Onward use is unknown
- Evidence
- Dashboard is the only record
- Failure
- Loss is silent
- Exit
- Records stay captive
Illustrative scoring example, not a test of named products. Score each candidate from 1 to 5. Use these weights: purpose 25, access 20, data 20, evidence 15, failure 10, exit 10.
Weighted totals
| Candidate | Purpose | Access | Data | Evidence | Failure | Exit | Weighted total |
|---|---|---|---|---|---|---|---|
| A | 5 | 4 | 4 | 3 | 4 | 2 | 3.9 |
| B | 4 | 5 | 3 | 4 | 3 | 4 | 3.9 |
| C | 3 | 4 | 5 | 4 | 4 | 5 | 4.05 |
Set a reject rule before you score: any exit score below 3 disqualifies a candidate. Candidate A scores 3.9 but fails that rule. Candidate C leads on total, if the team accepts its lower purpose score.
Add a U.S. healthcare compliance gate
For tools that handle protected health information (PHI), document whether HIPAA applies and review the relevant HIPAA Privacy, Security, and Breach Notification Rule obligations with your privacy officer. Confirm whether the vendor is acting as a business associate; when it is, put a business associate agreement (BAA) in place before sharing PHI. The U.S. Department of Health and Human Services Office for Civil Rights (HHS OCR) administers and enforces HIPAA.
Add a separate privacy, security and compliance column to each scorecard. Use the same 1-to-5 scale to assess documented access controls, audit logs, incident response, retention and deletion, and evidence for applicable legal obligations. Record this score separately from the six-dimension weighted total above, and make unresolved legal or security failures a disqualifier rather than allowing a strong feature score to offset them.
Before calls or texts, check applicable Telephone Consumer Protection Act (TCPA) consent and opt-out requirements. For commercial email, check the CAN-SPAM Act requirements. For consumer health products, ask counsel whether the Federal Trade Commission Act and FTC Health Breach Notification Rule apply. Review applicable state requirements too, such as California's Confidentiality of Medical Information Act and Washington's My Health My Data Act, where their scope reaches your organization or data.
For patient-facing interfaces, assess applicable Americans with Disabilities Act (ADA) obligations and use Web Content Accessibility Guidelines (WCAG) 2.2 AA as an accessibility test benchmark.
Pilot and reassess
- Pilot with synthetic records on one service line.
- Test permissions, logs, alerts, correction and deletion.
- Record version, configuration, tester, defects and decisions.
- Reassess after a major release or a data-dictionary change.
Weigh the operating burden
Treat the two GOV.UK references as supplementary prompts about adaptable, portable choices, not as a U.S. legal or compliance framework.
The GOV.UK technology selection guidance asks for adaptable choices, data control, security review and whole-life cost. Those questions transfer to practice marketing tools; they are not endorsements.
The GOV.UK open standards guidance ties open standards to interoperability and lower supplier dependence. Test whether patient acquisition tools let your definitions and data move, then judge the answer against your own contract terms.
Give every candidate the same source sample, user roles, required output, failure case and export task. Time the setup, the recurring labor, the specialist help, the correction work and the shutdown. Credit a feature only when an intended user completes the task safely.
Pricing models differ. Small-practice scheduling and reminder tools are often priced per provider per month, with typical list prices from around $50 to $300. Reputation and CRM suites often run from around $200 to $1,000 per location per month, plus implementation.
Call tracking usually charges a base fee plus per-number and per-minute rates, with typical entry plans from around $45 to $500 per month. These are typical ranges; ask for a current quote.
Keep the evidence with the decision
A product page today does not promise the same function or price next year, so save the tested plan and its date. Date the next review and name what would trigger it sooner, such as a major release or a data-dictionary update.
Feed one set of definitions through the interface, the export, the meeting note and the correction log.
Close unused reports and permissions when the cycle ends, and feed the rejection log into the patient acquisition benchmarks you compare next quarter.
Common questions
Which tool should a small team buy first?
Buy the one that fixes a verified defect in how patients enter care, and only if it also clears your access, data, evidence and exit requirements. A tool that fails the exit test costs more later than it saves now.
Does a client list prove a tool is suitable?
No. A logo wall shows someone signed a contract. Test the exact use, the configuration, the data path, the users and the failure modes against your own service line.
Can one platform be the source of truth?
Assign authority by field and process. Service, scheduling, referral and clinical facts may each belong to a different controlled record. Finance and marketing facts may also belong to different records. The marketing tool rarely owns the clinical one.
How often should we retest?
Retest after any major release, data-dictionary update or contract renewal, and at least once a year. Between tests, name an owner who can pause the tool if a correction path stops working.
